Immunotherapy in inflammatory bowel disease: Novel and emerging treatments
Inflammatory bowel disease (IBD) is a chronic disabling inflammatory process that affects young individuals, with growing incidence. The etiopathogenesis of IBD remains poorly understood. A combination of genetic and environmental factors triggers an inadequate immune response against the commensal...
Saved in:
Main Authors: | Ignacio Catalan-Serra (Author), Øystein Brenna (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel and Emerging Therapies for Inflammatory Bowel Disease
by: Badr Al-Bawardy, et al.
Published: (2021) -
Emerging treatments for inflammatory bowel disease
by: Karl Hazel, et al.
Published: (2020) -
Current and emerging drugs for the treatment of inflammatory bowel disease
by: Triantafillidis JK, et al.
Published: (2011) -
Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease-A Review of the Evidence
by: Joseph Meredith, et al.
Published: (2021) -
Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease
by: Caifang Gao, et al.
Published: (2019)